A bill for an act relating to insurance coverage for covered individuals for the treatment of autism spectrum disorder and including applicability provisions.(See HF 330.)
HF 5 would expand Iowa insurance mandates for autism spectrum disorder (ASD) treatment. The bill amends multiple sections of the insurance code to require broader coverage for diagnostic assessment and treatment of ASD, including applied behavior analysis (ABA), under certain group health policies and plans. It removes age-based limits in several places, so coverage would no longer be restricted to children or young adults in the same way current law does.
The bill also eliminates certain dollar caps and visit limits tied to autism coverage. For state employee group plans under chapter 509A, it removes the current maximum annual benefit amount and the age cap for covered individuals under 21. For other qualifying group policies and public employee plans, it removes age restrictions for ABA coverage and eliminates the annual benefit tiers that currently vary by age. The bill keeps coverage subject to the same deductibles, coinsurance, and copayments that apply to other comparable medical services, and it preserves the ability of plans to use care management tools such as prior authorization and visit limits for ABA in some settings.
The bill would change Iowa insurance law by broadening and standardizing autism-related coverage requirements across affected group health plans, with conforming terminology updates from “autistic disorders” to “autism spectrum disorder.” It applies to policies and plans delivered, issued, continued, or renewed on or after January 1, 2026. In practical terms, insurers, state employee plans, and certain public employee plans would face expanded coverage obligations and potentially higher claims exposure for ASD-related services.
The general sentiment reflected in the available record appears favorable. The House Commerce Committee reported the bill 23-0, indicating unanimous support among voting committee members. There is no committee transcript in the record, but the lack of recorded opposition and the committee vote suggest broad agreement with expanding autism coverage.
The main point of contention, based on the bill text itself, is the scope and cost of the mandate. By removing age limits and benefit caps, the bill would increase required coverage and could raise premiums or plan costs, which may concern insurers and employers. At the same time, the bill retains some utilization management tools, suggesting an attempt to balance expanded access with cost controls.
HF 5 would amend Iowa Code sections 514C.22, 514C.28, and 514C.31 to expand mandated insurance coverage for autism spectrum disorder treatment. It removes certain age restrictions, annual benefit caps, and visit limits for ASD-related coverage in specified group health policies and plans, while preserving general cost-sharing rules and some care management provisions. The bill would apply to affected policies and plans issued, renewed, or continued on or after January 1, 2026, affecting insurers, state employee plans, public employee plans, covered individuals, and providers of ASD services such as ABA practitioners and autism service providers.
The available legislative history suggests strong support for the bill. The House Commerce Committee reported HF 5 unanimously, 23-0, and there is no recorded committee opposition in the materials provided. That vote pattern indicates the bill was viewed positively as an expansion of autism-related health coverage, with little visible resistance at the committee stage.
The principal policy tension is between expanded access to autism treatment and the cost of requiring broader coverage. Supporters would likely favor removing age and dollar limits so individuals with autism can continue treatment beyond childhood and without exhausting annual caps. Potential critics may focus on increased insurance costs, premium impacts, and the reduced ability of plans to limit utilization, although the bill preserves some prior authorization and visit-management authority for ABA in certain contexts.